Cannabis testing market seen doubling to $8.72 billion by 2030

The Business Research Company says the cannabis testing market will grow from $4.26 billion in 2026 to $8.72 billion by 2030, driven by legalization, tighter regulation and demand for faster, more accurate testing. North America leads now, while Asia-Pacific is expected to be the fastest-growing region.

Why it matters: - Cannabis testing is becoming a bigger part of the legal cannabis supply chain as regulators, producers and labs focus on product safety, potency and contamination screening. - The market’s projected growth signals rising demand for faster, more reliable testing tools across medical and recreational cannabis markets.

What happened: - The Business Research Company released a cannabis testing market report projecting the global market will rise from $3.56 billion in 2025 to $4.26 billion in 2026. - The report forecasts the market will reach $8.72 billion by 2030, implying a 19.6% compound annual growth rate over the forecast period. - The company said the market is expanding as legalization spreads and regulatory requirements tighten worldwide. - The report is available as a free sample. - The full report is available here.

The details: - Cannabis testing measures THC, CBD and terpenes. - Testing also looks for residual solvents, molds, pests, diseases and pesticide residues. - The report links market growth to legalized cannabis expansion, higher safety requirements, growth in commercial cannabis production, broader use of lab-based testing and stronger consumer demand for product safety assurance. - Looking ahead, the report points to more investment in rapid testing technologies, real-time potency analysis, standardized testing regulations, handheld testing devices and digital laboratory management systems. - The report also highlights rising demand for comprehensive testing services, advanced chromatography methods, regulatory compliance testing and better data accuracy and traceability. - Cannabis testing has medicinal relevance because cannabis is used to help address stress, muscle pain, nausea and vomiting. - The company says the 2026 edition of its market reports includes market attractiveness scoring, total addressable market analysis, company scoring matrix graphics, Excel-based forecasting dashboards, market hotspot infographics, key technology and future trend analysis, and updated graphics and tables.

Between the lines: - The forecast suggests cannabis testing is shifting from a compliance function to a broader technology market tied to automation, digitization and faster field-based analysis. - The report’s emphasis on portable devices and digital lab systems points to a market where speed and traceability may matter as much as traditional lab accuracy. - A separate driver cited in the report is the growth in neurological disorders. The World Federation of Neurology said in October 2023 that more than 40% of the global population has some form of neurological condition, and that figure could nearly double by 2050.

What's next: - North America remains the largest cannabis testing market in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - More information is available from The Business Research Company’s contacts and social channels listed in the release.